Genetic polymorphisms of TP53‐binding protein 1 (TP53BP1) gene and association with breast cancer risk
暂无分享,去创建一个
[1] Bin Li,et al. Stimulation of p53-mediated Transcriptional Activation by the p53-binding Proteins, 53BP1 and 53BP2* , 1998, The Journal of Biological Chemistry.
[2] Y. Nakanishi,et al. Cigarette smoking, TP53 Arg72Pro, TP53BP1 Asp353Glu and the risk of lung cancer in a Japanese population. , 2010, Oncology reports.
[3] I. Ellis,et al. Pathological prognostic factors in breast cancer. , 1999, Critical reviews in oncology/hematology.
[4] Y. Shiloh. ATM and related protein kinases: safeguarding genome integrity , 2003, Nature Reviews Cancer.
[5] T. Rauch,et al. 53BP1 is a Positive Regulator of the BRCA1 Promoter , 2005, Cell cycle.
[6] Jiri Bartek,et al. 53BP1 functions in an ATM-dependent checkpoint pathway that is constitutively activated in human cancer , 2002, Nature Cell Biology.
[7] H. Bloom,et al. Histological Grading and Prognosis in Breast Cancer , 1957, British Journal of Cancer.
[8] R. Winqvist,et al. Germline alterations in the 53BP1 gene in breast and ovarian cancer families. , 2007, Cancer letters.
[9] J. Glover,et al. Crystal structure of the BRCT repeat region from the breast cancer-associated protein BRCA1 , 2001, Nature Structural Biology.
[10] C. Compton,et al. AJCC Cancer Staging Manual , 2002, Springer New York.
[11] S. Elledge,et al. 53BP1, a Mediator of the DNA Damage Checkpoint , 2002, Science.
[12] S. West,et al. Distinct functions of BRCA1 and BRCA2 in double-strand break repair , 2001, Breast Cancer Research.
[13] D. Livingston,et al. Structure of the 53BP1 BRCT region bound to p53 and its comparison to the Brca1 BRCT structure. , 2002, Genes & development.
[14] R. Naidu,et al. P27 V109G Polymorphism is associated with lymph node metastases but not with increased risk of breast cancer. , 2007, Journal of experimental & clinical cancer research : CR.
[15] Wei Zhang,et al. Polymorphic TP53BP1 and TP53 Gene Interactions Associated with Risk of Squamous Cell Carcinoma of the Head and Neck , 2007, Clinical Cancer Research.
[16] R. Naidu,et al. Polymorphism of FGFR4 Gly388Arg does not confer an increased risk to breast cancer development. , 2009, Oncology research.
[17] P. Bugert,et al. TP53-binding protein variants and breast cancer risk: a case-control study , 2005, Breast Cancer Research.
[18] S. Ganesan,et al. Evaluation of single nucleotide polymorphisms (SNPs) in the p53 binding protein 1 (TP53BP1) gene in breast cancer patients treated with breast-conserving surgery and whole-breast irradiation (BCS + RT). , 2009, International journal of radiation oncology, biology, physics.
[19] S. Fields,et al. Two cellular proteins that bind to wild-type but not mutant p53. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[20] Donald L Weaver,et al. Revision of the American Joint Committee on Cancer staging system for breast cancer. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[21] T. Halazonetis,et al. P53 Binding Protein 1 (53bp1) Is an Early Participant in the Cellular Response to DNA Double-Strand Breaks , 2000, The Journal of cell biology.
[22] I. Ellis,et al. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. , 2002, Histopathology.
[23] A. Sancar,et al. Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. , 2004, Annual review of biochemistry.
[24] Junjie Chen,et al. Tumor Suppressor P53 Binding Protein 1 (53bp1) Is Involved in DNA Damage–Signaling Pathways , 2001, The Journal of cell biology.
[25] Hongbing Shen,et al. Joint effects of single nucleotide polymorphisms in P53BP1 and p53 on breast cancer risk in a Chinese population. , 2006, Carcinogenesis.